{"nct_id":"NCT00678886","title":"Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2008-07-29","start_date_type":"ACTUAL","primary_completion_date":"2012-01-31","primary_completion_date_type":"ACTUAL","completion_date":"2012-01-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}